Is LCTX up or down today?
LCTX is up 8.70% today, last at 1.03. This stock moved +8.70% versus the prior close.
LCTX · LCTX
LCTX (LCTX) is trading at 1.03, up 8.70% on the session. LCTX sits at the 12% mark of its 52-week range, carries a 14-day RSI of 53, and trades below its 50-day average. Over the past month it is down 5.50%.
Leading the coverage: “LCTX Dec 2026 2.000 call (LCTX261218C00002000) stock price, news, quote and history - Yahoo Finance UK” (Google News, 8d ago). LCTX is -1.04% since story.
LCTX trades on a trailing P/E of 13.4 and is running 6.54% behind the S&P 500 over the same stretch.
Analyst firms are mostly reiterating — no strong directional shift lately.
LCTX is up 8.70% today, last at 1.03. This stock moved +8.70% versus the prior close.
Leading the coverage: “LCTX Dec 2026 2.000 call (LCTX261218C00002000) stock price, news, quote and history - Yahoo Finance UK” (Google News, 8d ago). LCTX is -1.04% since story. Dominant story: LCTX Q2 2026 Earnings: Positive EPS of $0.01 Against an Expected Loss - Full Year Guidance - https://www.siam.in/ (1 source, neutral) RSI is 53 — neutral Price below 50-day average — short-term weakness Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Loaded: Apr 2026 – Oct 2026 (125 days) · Drag or scroll left for earlier dates
LCTX Q2 2026 Earnings: Positive EPS of $0.01 Against an Expected Loss - Full Year Guidance - https://www.siam.in/
LCTX Dec 2026 2.000 call (LCTX261218C00002000) stock price, news, quote and history - Yahoo Finance UK
LCTX Jumps As Lineage Wins Long-Dated AlloSCOPE Patent - Timothy Sykes
Lineage Cell Therapeutics (LCTX) Slips to $1.02 as Shares Drift Toward Lower Support - Rating Change - https://www.siam.in/
Lineage Cell Therapeutics Announces Issuance of Patent Underlying Its AlloSCOPE™ 5D Manufacturing Platform